Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Vitamins and plant ingredients

Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults

Abstract

Background/Objectives:

Animal studies have demonstrated that soy isoflavones exert antidiabetic effects. However, evidence regarding the association between soyfood intake, a unique source of isoflavones, and type 2 diabetes remains inconclusive. This study assessed the relationship between habitual intakes of soyfoods and major isoflavones and risk of type 2 diabetes in Vietnamese adults.

Subjects/Methods:

A hospital-based case-control study was conducted in Vietnam during 2013–2015. A total of 599 newly diagnosed diabetic cases (age 40–65 years) and 599 hospital-based controls, frequency matched by age and sex, were recruited in Hanoi, capital city of Vietnam. Information on frequency and quantity of soyfood and isoflavone intake, together with demographics, habitual diet and lifestyle characteristics, was obtained from direct interviews using a validated and reliable questionnaire. Unconditional logistic regression analyses were performed to examine the association between soy variables and type 2 diabetes risk.

Results:

Higher intake of total soyfoods was significantly associated with a lower risk of type 2 diabetes; the adjusted odds ratio (OR) for the highest versus the lowest intake was 0.31 (95% confidence interval (CI): 0.21–0.46; P<0.001). An inverse dose–response relationship of similar magnitude was also observed for total isoflavone intake (OR: 0.35; 95% CI: 0.24 to 0.49; P<0.001). In addition, inverse associations of specific soyfoods (soy milk, tofu and mung bean sprout) and major isoflavones (daidzein, genistein and glycitein) with the type 2 diabetes risk were evident.

Conclusions:

Soyfood and isoflavone intake was associated with a lower type 2 diabetes risk in Vietnamese adults.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. International Diabetes Federation IDF Diabetes Atlas 2015.

  2. N. C. D. Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387: 1513–1530.

    Article  Google Scholar 

  3. Esposito K, Chiodini P, Maiorino MI, Bellastella G, Panagiotakos D, Giugliano D . Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine 2014; 47: 107–116.

    Article  CAS  Google Scholar 

  4. Murphy PA, Barua K, Hauck CC . Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 129–138.

    Article  CAS  Google Scholar 

  5. Messina M, Nagata C, Wu AH . Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006; 55: 1–12.

    Article  CAS  Google Scholar 

  6. Talaei M, Pan A . Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes 2015; 6: 271–283.

    Article  Google Scholar 

  7. Kwon DY, Daily JW 3rd, Kim HJ, Park S . Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 2010; 30: 1–13.

    Article  CAS  Google Scholar 

  8. Cho KW, Lee OH, Banz WJ, Moustaid-Moussa N, Shay NF, Kim YC . Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J Nutr Biochem 2010; 21: 841–847.

    Article  CAS  Google Scholar 

  9. Villegas R, Gao Y-T, Yang G, Li H-L, Elasy TA, Zheng W et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 2008; 87: 162–167.

    Article  CAS  Google Scholar 

  10. Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M et al. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 2010; 140: 580–586.

    Article  CAS  Google Scholar 

  11. Mueller NT, Odegaard AO, Gross MD, Koh WP, Yu MC, Yuan JM et al. Soy intake and risk of type 2 diabetes in Chinese Singaporeans. Eur J Nutr 2012; 51: 1033–1040.

    Article  CAS  Google Scholar 

  12. Tatsumi Y, Morimoto A, Deura K, Mizuno S, Ohno Y, Watanabe S . Effects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku Study. J Diabetes Investig 2013; 4: 626–633.

    Article  CAS  Google Scholar 

  13. Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G . Soy consumption is not protective against diabetes in Hawaii: The Multiethnic Cohort. Eur J Clin Nutr 2011; 65: 279–282.

    Article  CAS  Google Scholar 

  14. Ding M, Pan A, Manson JE, Willett WC, Malik V, Rosner B et al. Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts. Eur J Clin Nutr 2016; 70: 1381–1387.

    Article  CAS  Google Scholar 

  15. Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M et al. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care 2013; 36: 3961–3970.

    Article  CAS  Google Scholar 

  16. Ding M, Franke AA, Rosner BA, Giovannucci E, van Dam RM, Tworoger SS et al. Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women. Br J Nutr 2015; 114: 1694–1701.

    Article  CAS  Google Scholar 

  17. Ozen AE, Pons A, Tur JA . Worldwide consumption of functional foods: a systematic review. Nutr Rev 2012; 70: 472–481.

    Article  Google Scholar 

  18. Inbaraj BS, Chen BH . Isoflavone ingestion by multiethnic populations: implications for health. In: Preedy VR (ed) Isoflavones: Chemistry, Analysis, Function and Effects. RSC Publishing: Cambridge, 2013, pp 349–364.

    Google Scholar 

  19. Nguyen CT, Pham NM, Lee AH, Binns CW . Prevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic review. Asia Pac J Public Health 2015; 27: 588–600.

    Article  Google Scholar 

  20. Pham NM, Eggleston K . Diabetes prevalence and risk factors among Vietnamese adults: findings from community-based screening programs. Diabetes Care 2015; 38: e77–e78.

    Article  Google Scholar 

  21. Huong NT, Ward M Vietnam oilseeds and products soybean meal and vegetable oil update. GAIN Report Number: VM5019 (2015).

  22. Nguyen CT, Pham NM, Tran DV, Lee AH, Binns CW . Lifestyle and diet in relation to risk of type 2 diabetes in Vietnam: a hospital-based case-control study. Springerplus 2016; 5: 687.

    Article  Google Scholar 

  23. The World Health Organization Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF consultation: Geneva, 2006.

  24. Van Tran D, Van Hoang D, Nguyen CT, Lee AH . Validity and reliability of a food frequency questionnaire to assess habitual dietary intake in Northern Vietnam. Vietnam J Pub Health 2013; 1: 57–64.

    Google Scholar 

  25. Bhagwat S, Haytowitz DB, Holden JM . USDA Database for the isoflavone Content of Selected Foods Release 2.0. US Department of Agriculture: Maryland, 2008; 15.

    Google Scholar 

  26. Willett WC, Howe GR, Kushi LH . Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S–1228S. discussion 1229S–1231S.

    Article  CAS  Google Scholar 

  27. Zhang M, Lee AH, Binns CW . Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer 2003; 105: 838–843.

    Article  CAS  Google Scholar 

  28. World Health Organization STEPwise approach to surveillance, 2002. Available at http://www.who.int/chp/steps/en/ (accessed 20 October 2016).

  29. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.

    Article  CAS  Google Scholar 

  30. Hsieh CC, Maisonneuve P, Boyle P, Macfarlane GJ, Roberston C . Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects? Epidemiology 1991; 2: 137–140.

    Article  CAS  Google Scholar 

  31. Durrleman S, Simon R . Flexible regression models with cubic splines. Stat Med 1989; 8: 551–561.

    Article  CAS  Google Scholar 

  32. Ko KP, Kim CS, Ahn Y, Park SJ, Kim YJ, Park JK et al. Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study. Diabetologia 2015; 58: 726–735.

    Article  CAS  Google Scholar 

  33. Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q et al. Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur J Clin Nutr 2004; 58: 615–620.

    Article  CAS  Google Scholar 

  34. Nakamoto M, Uemura H, Sakai T, Katsuura-Kamano S, Yamaguchi M, Hiyoshi M et al. Inverse association between soya food consumption and insulin resistance in Japanese adults. Public Health Nutr 2015; 18: 2031–2040.

    Article  Google Scholar 

  35. Talaei M, Lee BL, Ong CN, van Dam RM, Yuan JM, Koh WP et al. Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study. Br J Nutr 2016; 115: 1607–1615.

    Article  CAS  Google Scholar 

  36. Liu ZM, Chen YM, Ho SC . Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011; 93: 1092–1101.

    Article  CAS  Google Scholar 

  37. Lee SA, Wen W, Xiang YB, Barnes S, Liu D, Cai Q et al. Assessment of dietary isoflavone intake among middle-aged Chinese men. J Nutr 2007; 137: 1011–1016.

    Article  Google Scholar 

  38. Setchell KD . Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68: 1333S–1346S.

    Article  CAS  Google Scholar 

  39. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A . Bioavailability of phyto-oestrogens. Br J Nutr 2003; 89 (Suppl 1), S45–S58.

    CAS  PubMed  Google Scholar 

  40. Chen L, Zhang YH, Huang T, Cai YD . Gene expression profiling gut microbiota in different races of humans. Sci Rep 2016; 6: 23075.

    Article  CAS  Google Scholar 

  41. Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834–841.

    Article  CAS  Google Scholar 

  42. Setchell KD, Clerici C . Equol: history, chemistry, and formation. J Nutr 2010; 140: 1355S–1362S.

    Article  CAS  Google Scholar 

  43. Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ et al. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 2006; 79: 1207–1213.

    Article  Google Scholar 

  44. Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review. Biochem Pharmacol 2014; 92: 73–89.

    Article  CAS  Google Scholar 

  45. Kostelac D, Rechkemmer G, Briviba K . Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 2003; 51: 7632–7635.

    Article  CAS  Google Scholar 

  46. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004; 12: 1559–1567.

    Article  CAS  Google Scholar 

  47. Ding EL, Song Y, Malik VS, Liu S . Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288–1299.

    Article  CAS  Google Scholar 

  48. Greenland S, Lash TL . Bias analysis. In: Rothman KJ, Greenland S, Lash TL (eds) Modern Epidemiology, 3rd edn. Lippincott–Raven: Philadelphia, 2008.

    Google Scholar 

  49. Orsini N, Bellocco R . A tool for deterministic and probabilistic sensitivity analysis of epidemiologic studies. Stat J 2008; 8: 29–48.

    Article  Google Scholar 

  50. Ho-Pham LT, Do TT, Campbell LV, Nguyen TV . HbA1c-based classification reveals epidemic of diabetes and prediabetes in Vietnam. Diabetes Care 2016; 39: e93–e94.

    Article  Google Scholar 

Download references

Acknowledgements

We are indebted to the study participants who agreed to be interviewed. Thanks are also due to the medical and nursing staff of the participating hospital for their assistance in subject recruitment. The research was financially supported by the researchers’ institutions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A H Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, C., Pham, N., Do, V. et al. Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults. Eur J Clin Nutr 71, 1186–1192 (2017). https://doi.org/10.1038/ejcn.2017.76

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2017.76

This article is cited by

Search

Quick links